“We have taken the first step towards a novel treatment for cancer. The results show that antiprotons are four times more effective than protons at terminating live cells. Although it still has to be compared with other existing methods, it is a breakthrough in this area of investigation.” says Michael Doser at CERN, one of the scientists collaborating on the experiment. ACE brings together a team of experts in the fields of physics, biology, and medicine from 10 institutes around the world.
Current particle beam therapy commonly uses protons to destroy tumour cells inside a patient. The ACE experiment directly compared the effectiveness of cell irradiation using protons and antiprotons. To simulate a cross-section of tissue inside a body, tubes were filled with hamster cells suspended in gelatine. Researchers sent a beam of protons or antiprotons with a range of 2 cm depth into one end of the tube, and evaluated the fraction of surviving cells after irradiation along the path of the beam.
The results showed that antiprotons were four times more effective than protons. When comparing a beam of antiprotons with a beam of protons that cause identical damage at the entrance to the target, the experiment found the damage to cells inflicted at the end of the beam path to be four times higher for antiprotons than for protons. Michael Holzscheiter, spokesperson of the ACE experiment, summarises: “To achieve the same level of damage to cells at the target area one needs four times fewer antiprotons than protons. This significantly reduces the damage to the cells along the entrance channel of the beam for antiprotons compared to protons. Due to the antiproton's unsurpassed ability to preserve healthy tissue while causing damage to a specific area, this type of beam could be highly valuable in treating cases of recurring cancer, where this property is vital.”
Antiprotons are antimatter; they have to be produced in small amounts in a laboratory with the help of a particle accelerator. When matter and antimatter particles meet, they annihilate, or destroy each other, transforming their mass into energy. The experiment makes use of this property as the antiproton would annihilate with a part of the nucleus of an atom in a tumour cell. The fragments produced from the energy released by the annihilation would be projected into adjacent tumour cells, which are in turn destroyed.
“CERN is a unique facility for this work. It is the only place in the world where an antiproton beam of sufficiently low energy and high quality is available. This is crucial for our research. Without access to the antiproton decelerator facility, these experiments would simply not have been possible.” says Niels Bassler, co-spokesperson of ACE. “This experiment is a fantastic example of how research in particle physics can generate innovative solutions with potential medical benefits.”
Researchers are currently conducting more tests to irradiate cells at a greater depth (about 15cm below the surface). Experiments to compare the effectiveness of antiprotons with another form of treatment using carbon ions will begin next month at GSI (Gesellschaft für Schwerionenforschung) in Germany. Further tests are planned to fully assess the effectiveness and suitability of antiprotons for cancer therapy, and to assure that less damage is caused to healthy tissues compared to other methods.
If all goes well, the first clinical application would still be a decade or more into the future.
Michael Holzscheiter | alfa
Sharpening the X-ray view of the nanocosm
23.03.2018 | Changchun Institute of Optics, Fine Mechanics and Physics
Drug or duplicate?
23.03.2018 | Fraunhofer-Institut für Angewandte Festkörperphysik IAF
Satellites in near-Earth orbit are at risk due to the steady increase in space debris. But their mission in the areas of telecommunications, navigation or weather forecasts is essential for society. Fraunhofer FHR therefore develops radar-based systems which allow the detection, tracking and cataloging of even the smallest particles of debris. Satellite operators who have access to our data are in a better position to plan evasive maneuvers and prevent destructive collisions. From April, 25-29 2018, Fraunhofer FHR and its partners will exhibit the complementary radar systems TIRA and GESTRA as well as the latest radar techniques for space observation across three stands at the ILA Berlin.
The "traffic situation" in space is very tense: the Earth is currently being orbited not only by countless satellites but also by a large volume of space...
An international team of researchers has discovered a new anti-cancer protein. The protein, called LHPP, prevents the uncontrolled proliferation of cancer cells in the liver. The researchers led by Prof. Michael N. Hall from the Biozentrum, University of Basel, report in “Nature” that LHPP can also serve as a biomarker for the diagnosis and prognosis of liver cancer.
The incidence of liver cancer, also known as hepatocellular carcinoma, is steadily increasing. In the last twenty years, the number of cases has almost doubled...
In just a few weeks from now, the Chinese space station Tiangong-1 will re-enter the Earth's atmosphere where it will to a large extent burn up. It is possible that some debris will reach the Earth's surface. Tiangong-1 is orbiting the Earth uncontrolled at a speed of approx. 29,000 km/h.Currently the prognosis relating to the time of impact currently lies within a window of several days. The scientists at Fraunhofer FHR have already been monitoring Tiangong-1 for a number of weeks with their TIRA system, one of the most powerful space observation radars in the world, with a view to supporting the German Space Situational Awareness Center and the ESA with their re-entry forecasts.
Following the loss of radio contact with Tiangong-1 in 2016 and due to the low orbital height, it is now inevitable that the Chinese space station will...
Fraunhofer Institute for Organic Electronics, Electron Beam and Plasma Technology FEP, provider of research and development services for OLED lighting solutions, announces the founding of the “OLED Licht Forum” and presents latest OLED design and lighting solutions during light+building, from March 18th – 23rd, 2018 in Frankfurt a.M./Germany, at booth no. F91 in Hall 4.0.
They are united in their passion for OLED (organic light emitting diodes) lighting with all of its unique facets and application possibilities. Thus experts in...
A new scenario seeking to explain how Mars' putative oceans came and went over the last 4 billion years implies that the oceans formed several hundred million...
23.03.2018 | Event News
19.03.2018 | Event News
16.03.2018 | Event News
23.03.2018 | Materials Sciences
23.03.2018 | Agricultural and Forestry Science
23.03.2018 | Physics and Astronomy